News

COVID-19: Clinical Trial For Avigan To Begin In Kuwait

TOKYO, July 21  — A clinical trial for the influenza drug Avigan, a potential treatment for the COVID-19 disease caused by the novel coronavirus, will begin in Kuwait as early as this month, Jiji Press quoted informed sources Monday.

Up to 1,000 people are expected to participate in the trial to confirm the efficacy and safety of the drug as a coronavirus remedy.

Data collected through the trial may be used in applications for approval of the drug in Japan.

The trial will be led by Indian generic drugmaker Dr Reddy’s Laboratories Ltd, with whom Fujifilm Corp has signed a licensing contract for the overseas manufacturing and sales of Avigan.

The Japanese company will support the trial by supplying the drug.

Fujifilm Toyama Chemical Co, the Fujifilm subsidiary that developed Avigan, began a clinical trial in Japan in late March with a target of 96 participants.

The trial was slated to end in late June, but the end date has been pushed back due to a decline in the number of participants.

Source: BERNAMA

Adib Mohd

Recent Posts

LG’s New MAGNIT Active Micro LED: When Your Living Room Becomes a Luxury Cinema

LG is taking “movie night at home” to the next level. Introducing the LG MAGNIT… Read More

3 hours ago

The Touch of Fall: Kate Spade’s Loop and Halo Bags Bring Cozy-Chic Energy This Season

Fall isn’t just a season, it’s a mood. And Kate Spade New York is serving… Read More

3 hours ago

The First 72 Hours After a Stroke, Crucial for Recovery and Saving Lives

Did you know that you could lose approximately 1.9 million neurons after a stroke hit?… Read More

22 hours ago

Huawei ICT Academy Will Level Up Your Digital Mastery

Huawei Technologies (Malaysia) Sdn Bhd (Huawei Malaysia) and Universiti Teknologi MARA (UiTM) Johor are collaborating… Read More

22 hours ago

Malaysia Faces Rising Dementia Care Burden as Families Struggle Alone

Malaysia Faces Rising Dementia Care Burden as Families Struggle Alone Malaysia’s rapidly aging population is… Read More

1 day ago

From Oval Office to Silver Screen: Trump Cameo Legacy You Can Never Recreate

From Oval Office to Silver Screen: Trump Cameo Legacy You Can Never Recreate Imagine you… Read More

1 day ago

This website uses cookies.